Elusys Therapeutics INC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersBoca Raton, FL
SAM.gov UEIELP1DCK8L191
Elusys Therapeutics develops medical countermeasures for bioterrorism and biological threats, specifically ANTHIM®, an FDA-approved monoclonal antibody antitoxin designed to treat inhalational anthrax when used with antibacterial therapy. The company serves U.S. Government and global health security partners, with products that are domestically sourced and produced for stockpiling and rapid response deployment.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Elusys Therapeutics INC | Boca Raton | FL | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.